Approval · Notice of Compliance 8068 · 2006
OPTIMARK: Notice of Compliance 8068
Issued June 22, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8068
- Date
- June 22, 2006
- Company
- Tyco HealthcarePointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised injection rate
- Therapeutic class
- Paramagnetic, intravascular, contrast agent for magnetic resonnance imaging (mri)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPTIMARK | Not yet assigned | — |
Medicinal ingredients
- GADOVERSETAMIDE 330.9 MG per ML